![200000274.jpg](/community/proxy.php?image=http%3A%2F%2Fimages.ddccdn.com%2Fimages%2Fpills%2Fnlm%2F200000274.jpg&hash=d70d36369697554924ef0e466f6c3de2)
93 782 (Tamoxifen 20 mg)
http://www.drugs.com/imprints/93-782-7872.html
Pill imprint 93 782 has been identified as Tamoxifen citrate 20 mg.
Tamoxifen is used in the treatment of breast cancer, adjuvant; breast cancer, metastatic; breast cancer; breast cancer, prevention; breast cancer, male (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not subject to the Controlled Substances Act.
AHI (Anastrozole 1 mg)
Pill imprint AHI has been identified as Anastrozole 1 mg.
Anastrozole is used in the treatment of breast cancer; breast cancer, metastatic; mccune-albright syndrome; pubertal gynecomastia; endometrial cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Anastrozole 1 mg is not subject to the Controlled Substances Act.
![7b2CjZv.jpg](/community/proxy.php?image=http%3A%2F%2Fi.imgur.com%2F7b2CjZv.jpg&hash=bc885b765758051107b69772ed01d008)